With the highest rate of patients recovered from COVID-19 in the Americas -94.2% as of March 20 – and two candidate vaccines in the final stage of clinical trials, Cuba is consolidating its national strategy to confront the pandemic…

Soberana 02- As the COVID-19 battle continues, the Cuban candidate vaccine becomes the first of its kind in Latin America to reach this stage

From science: recent results which included an update on the development of a diagnostic based on magnetic extraction of virus RNA using nanotechnology.

Cuba shows significant results after almost a year of tackling COVID-19

On Twitter, the Cuba’s head of State also attached a link to Juventud Rebelde newspaper that published opinions of personalities of culture and politics about Leal, who died on Friday at the age of 77, from a painful disease.

The new partnership aims to provide broader access to BioCubaFarma’s patent-protected portfolio of biopharmaceutical products, developed by the pharmaceutical and biotechnology industry in Cuba